Adel A. Alharf

Adel A. Alharf is a seasoned professional in the pharmaceutical sector, currently serving as the Vice President of the Drug Sector at the SFDA since May 2004. With extensive experience in adverse event surveillance, pharmacoepidemiology, and risk management, Adel also held roles such as Executive Director of the Vigilance and Benefit/Risk Assessment Directorate and Director of the National Pharmacovigilance & Drug Safety Center. Previous experience includes serving as a Senior Pharmacist and Pharmacist at the SAIP from May 2018 to January 2022, where Adel also contributed as a Board Member. Educational credentials include a PhD in Medicine and Therapeutics from the University of Glasgow, an MSc in Pharmacology from King's College London, and various certifications in leadership and management from prestigious institutions such as The Wharton School and Harvard Business School.